Anti-Ischemic Activity of Fabomotizole Hydrochloride under Conditions of Endothelial Dysfunction


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Anti-ischemic activity of fabomotizole hydrochloride was studied on the model of subendocardial ischemia in rats with endothelial dysfunction. Endothelial dysfunction was modeled by intragastric administration of methionine (3 g/kg, once a day for 7 days). Acute subendocardial ischemia was induced in narcotized rats by intraperitoneal injection of isoproterenol (20 μg/kg/min over 5 min). Fabomotizole hydrochloride (intraperitoneally, 15 mg/kg) significantly reduced isoproterenol-induced ST segment depression in animals with endothelial dysfunction and with intact vasculature.

Sobre autores

I. Tsorin

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Rússia, Moscow

V. Barchukov

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Rússia, Moscow

M. Vititnova

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Rússia, Moscow

S. Kryzhanovskii

V. V. Zakusov Research Institute of Pharmacology

Autor responsável pela correspondência
Email: SAK-538@yandex.ru
Rússia, Moscow

S. Seredenin

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies